This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pharmacyclics Inc
PCYC : NASDAQ : Health Care
$124.39 | %
Today's Range: 123.01 - 124.99
Avg. Daily Volume: 1,063,000
08/29/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
PCYC PHARMACYCLICS INC 118.54 8922.51 106.79 435.04 606.45
INCY INCYTE CORP 50.19 8452.60 n/m 371.57 7.05
MDVN MEDIVATION INC 85.33 6552.41 316.04 391.92 79.56
ICPT INTERCEPT PHARMA INC 280.52 5952.07 n/m 1.66 -4.43
ITMN INTERMUNE INC 53.21 5745.03 n/m 111.42 173.85
SGEN SEATTLE GENETICS INC 42.50 5246.54 n/m 274.96 12.39
REGN REGENERON PHARMACEUTICALS 341.51 33839.20 97.30 2498.88 43.64
ALXN ALEXION PHARMACEUTICALS INC 166.47 32930.26 83.65 1921.43 45.15
VRTX VERTEX PHARMACEUTICALS INC 88.99 21186.92 n/m 829.73 -36.62
GRFS GRIFOLS SA 38.51 14707.33 24.37 4186.52 16.79
BMRN BIOMARIN PHARMACEUTICAL INC 69.37 10205.51 n/m 627.09 19.49
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PCYC Ind Avg S&P 500
106.79 79.66 19.76
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs